跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Resdilsin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Resdilsin
Approved
STANDARD
Resdilsin
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d82d1f4bf708eafa
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
d82d1f4bf708eafa
Drug Approval Philippines Name
Resdilsin
Product Name
Resdilsin
Registration Number
DRP-2198
Brand Name
Resdilsin
Generic Name
Salbutamol (As Sulfate) + Guaifenesin
Dosage Form
Film-Coated Tablet
Dosage Strength
2 mg / 100 mg
Manufacturer
Hizon Laboratories, Inc.
Trader
JRalph Pharmaceuticals, Inc.
Distributor
One Pharma Marketing Inc.
Issuance Date
25 April 2022
Expiry Date
08 May 2027
Pharmacologic Category
Bronchodilator/Expectorant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d82d1f4bf708eafa
Type
Standard
Back to Philippines FDA Approvals